ClinConnect ClinConnect Logo
Search / Trial NCT06030570

Effect of an Interdisciplinary Spine Rehabilitation Program

Launched by KU LEUVEN · Sep 7, 2023

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a rehabilitation program called Revita, designed to help people with chronic low back pain and other spine issues. The goal is to see how effective this program is in improving the health and well-being of patients with these conditions. The research is taking place at University Hospitals Leuven, and they are currently looking for participants who are adults over 18 years old and have been experiencing spine problems for more than six weeks. Eligible participants should also be willing to join the Revita program and understand the process well enough to give informed consent.

If you decide to participate, you can expect to take part in rehabilitation sessions that last about two hours. These sessions will include exercises aimed at improving your spine health. It's important to note that the trial is not open to everyone; for example, individuals who don’t speak Dutch well or cannot participate in the exercises will not be eligible. This study aims to help improve treatment options for patients with long-lasting spine pain, so your involvement could contribute to important findings in this area.

Gender

ALL

Eligibility criteria

  • Inclusion criteria
  • Adults, age \> 18 years
  • Spine problem for \> 6 weeks, needing interdisciplinary care (risk factors, failure of first line treatment, etc)
  • Inclusion in Revita program
  • Informed consent to participate
  • Exclusion criteria
  • Patients without sufficient understanding of the Dutch language
  • Unable to participate in 2h rehabilitation sessions with exercises

About Ku Leuven

KU Leuven, a prestigious research university located in Belgium, is renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, KU Leuven integrates cutting-edge research with clinical practice, facilitating the development of new therapeutic strategies and medical technologies. The institution's robust infrastructure and expertise in various fields, including biotechnology, pharmacology, and public health, position it as a leader in conducting high-quality clinical research that adheres to rigorous ethical standards and regulatory requirements. Through its clinical trials, KU Leuven aims to contribute significantly to the global biomedical landscape and enhance health outcomes for diverse populations.

Locations

Leuven, , Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported